142 related articles for article (PubMed ID: 21193276)
1. Combination of vascular endothelial growth factor antisense oligonucleotide therapy and radiotherapy increases the curative effects against maxillofacial VX2 tumors in rabbits.
Zheng LF; Li YJ; Wang H; Zhao JL; Wang XF; Hu YS; Zhang GX
Eur J Radiol; 2011 May; 78(2):272-6. PubMed ID: 21193276
[TBL] [Abstract][Full Text] [Related]
2. Studies of pathology and VEGF expression in rabbit cerebrospinal fluid metastasis: application of dynamic contrast-enhanced MRI.
Li KA; Zhang RM; Zhang F; Zhao JL; Li YJ; Wang XF; Zheng LF; Hu YS; Zhang GX
Magn Reson Imaging; 2011 Oct; 29(8):1101-9. PubMed ID: 21868183
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy of transcatheter arterial chemoembolization and arterial administration of antiangiogenesis on VX2 liver tumor.
Deng G; Zhao DL; Li GC; Yu H; Teng GJ
Cardiovasc Intervent Radiol; 2011 Aug; 34(4):824-32. PubMed ID: 21671151
[TBL] [Abstract][Full Text] [Related]
5. [The effect of VEGF antisense oligonucleotides combined with low molecular weight heparin on the growth and metastasis of mice Lewis lung cancer].
Zhang YH; Wang C; Pang BS; Zhai ZG; Weng XZ
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(11):749-52. PubMed ID: 16681948
[TBL] [Abstract][Full Text] [Related]
6. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor antisense oligonucleotides inhibit leptomeningeal metastasis in vivo.
Li K; Zhang G; Zhao J; Wang X; Li Y; Hu Y
Med Oncol; 2011 Dec; 28(4):1116-22. PubMed ID: 20503106
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of rabbits bearing advanced VX2 tumors in the mammary gland with nano-sized liposomal adriamycin administered by various routes].
Chen JH; Li Y; Yao Q; Ling R; Wang L; Li KZ; Wang Z; Chen T
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3039-42. PubMed ID: 16324402
[TBL] [Abstract][Full Text] [Related]
9. Modified model of VX2 tumor overexpressing vascular endothelial growth factor.
Pascale F; Ghegediban SH; Bonneau M; Bedouet L; Namur J; Verret V; Schwartz-Cornil I; Wassef M; Laurent A
J Vasc Interv Radiol; 2012 Jun; 23(6):809-817.e2. PubMed ID: 22498170
[TBL] [Abstract][Full Text] [Related]
10. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
11. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
[TBL] [Abstract][Full Text] [Related]
12. [Effect of vascular endothelial growth factor and tumor necrosis factor receptor for treatment of avascular necrosis of the femoral head in rabbits].
Hu ZM; Zhou MQ; Gao JM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2177-9. PubMed ID: 19114350
[TBL] [Abstract][Full Text] [Related]
13. Effect of transarterial pulsed perfusion with heated saline on tumor vascular permeability in a rabbit VX2 liver tumor model.
Cao W; Li JH; Feng DY; Wan Y; Liu YF; Yang QF; Cheng JW; Zhao SY; Zhang HX
Eur J Radiol; 2012 Mar; 81(3):e209-16. PubMed ID: 21345630
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor during the early stage of maxillofacial blast injury.
Zhang CJ; Li HZ; Zhou SX; Yang J; Huang QY
Chin J Dent Res; 2000 Dec; 3(4):40-3. PubMed ID: 11314086
[TBL] [Abstract][Full Text] [Related]
15. Using semi-quantitative dynamic contrast-enhanced magnetic resonance imaging parameters to evaluate tumor hypoxia: a preclinical feasibility study in a maxillofacial VX2 rabbit model.
Zheng L; Li Y; Geng F; Zheng S; Yan R; Han Y; Wang Q; Zhang Z; Zhang G
Am J Transl Res; 2015; 7(3):535-47. PubMed ID: 26045893
[TBL] [Abstract][Full Text] [Related]
16. [Effect of PCNA antisense oligooxynucleotides and VEGF antisense oligoxynucleotides on growth of hepatocellular carcinoma transplanted in nude mice].
Zhu J; Huang J; Chen Y
Zhonghua Wai Ke Za Zhi; 2001 Nov; 39(11):875-7. PubMed ID: 11930748
[TBL] [Abstract][Full Text] [Related]
17. VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer.
Hotz HG; Hines OJ; Masood R; Hotz B; Foitzik T; Buhr HJ; Gill PS; Reber HA
Surgery; 2005 Feb; 137(2):192-9. PubMed ID: 15674201
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].
Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells.
Aukunuru JV; Ayalasomayajula SP; Kompella UB
J Pharm Pharmacol; 2003 Sep; 55(9):1199-206. PubMed ID: 14604462
[TBL] [Abstract][Full Text] [Related]
20. [Effects of VEGF-A/VEGF-C antisense oligodeoxynucleotide on angiogenesis, lymphangiogenesis, and tumor growth of breast cancer].
Chen JS; Zhang YJ; Hu SE; Zhang HQ
Ai Zheng; 2007 Sep; 26(9):972-6. PubMed ID: 17927855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
